Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

(S)-N-Fmoc-Azetidine-2-Carboxylic Acid

    • Product Name (S)-N-Fmoc-Azetidine-2-Carboxylic Acid
    • Alias (S)-Fmoc-Aze-OH
    • Einecs 831-420-8
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    982890

    Product Name (S)-N-Fmoc-Azetidine-2-Carboxylic Acid
    Cas Number 161807-62-1
    Molecular Formula C18H17NO4
    Molecular Weight 311.34
    Appearance White to off-white solid
    Purity Typically ≥ 98%
    Optical Rotation [α]D20 +21° (c=1, MeOH)
    Melting Point 116-120°C
    Solubility Soluble in DMSO and DMF
    Storage Conditions Store at 2-8°C, protected from light and moisture

    As an accredited (S)-N-Fmoc-Azetidine-2-Carboxylic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing (S)-N-Fmoc-Azetidine-2-Carboxylic Acid is provided as a white powder in a sealed amber glass vial, 5 grams quantity.
    Shipping (S)-N-Fmoc-Azetidine-2-Carboxylic Acid is shipped in sealed, chemically compatible containers to prevent contamination and degradation. It is typically dispatched under ambient conditions, with careful handling instructions provided. Safety documentation (SDS) is included, and transit complies with all relevant chemical transport regulations to ensure product integrity and safety.
    Storage (S)-N-Fmoc-Azetidine-2-Carboxylic Acid should be stored in a cool, dry, and well-ventilated area, protected from moisture and direct sunlight. Keep the container tightly sealed when not in use. Store at 2-8°C (refrigerator) to maintain stability. Ensure the chemical is kept away from incompatible substances such as strong acids, bases, and oxidizers. Use appropriate laboratory safety protocols.
    Application of (S)-N-Fmoc-Azetidine-2-Carboxylic Acid

    Applications of (S)-N-Fmoc-Azetidine-2-Carboxylic Acid in Industrial Manufacturing

    As a specialist manufacturer of (S)-N-Fmoc-Azetidine-2-Carboxylic Acid, we consistently serve clients in high-value sectors where advanced amino acid derivatives are key intermediates in demanding synthesis pathways. The following detailed scenarios highlight validated downstream use cases, with industrial requirements and regulatory adherence reflected in process specifics and compliance standards.

    1. Peptide Therapeutics Manufacturing

    Peptide drug development heavily relies on enantiomerically pure building blocks for controlled sequence synthesis. Our material functions as a protected amino acid during solid-phase peptide synthesis (SPPS), offering both unique azetidine backbone constraints and Fmoc protection for orthogonal deprotection. Large-scale peptide APIs for antidiabetic and antitumor indications incorporate this group to enhance conformational rigidity and improve bioavailability. Adherence to regulatory and pharmacopoeial requirements under strict controlled conditions is critical for all production stages and release tests.

    Industry compliance standards

    • ICH Q7 GMP Guide for Active Pharmaceutical Ingredients
    • USP <823> Good Manufacturing Practices for Bulk Pharmaceuticals
    • FDA 21 CFR Part 211 – Finished Pharmaceuticals
    • Ph. Eur. 5.2.6 Peptide APIs

    Typical usage ratio

    • 5–25 mol% of total protected amino acids incorporated per peptide chain; ratio depends on specific sequence design, hydrophobicity balance, and intended conformation

    Downstream process integration

    • Direct insertion during SPPS cycles using automated synthesizers after manual weighing and dissolution in DMF or NMP
    • Fmoc removal via base treatment and subsequent N-terminal elongation controlled via HPLC in-process check

    Final product types

    • GMP-grade peptide active pharmaceutical ingredients (APIs)
    • Investigational peptide therapeutic candidates
    • Patent-protected peptide mimetics for clinical research
    • Reference standards for bioanalysis

    2. Pharmaceutical Intermediates for Heterocyclic Drugs

    Azetidine-based derivatives serve as advanced intermediates in multi-step syntheses of novel heterocyclic drugs, notably CNS and antiviral agents. Chemists use our product as a stereochemistry anchor for azetidine-containing scaffolds, allowing selective introduction of further functional groups without racemization. Custom synthesis units monitor the process for N-Fmoc cleavage and azetidine ring modification under controlled temperatures and inert atmospheres. Proper tracking of intermediate purity and documentation ensure compliance in regulated facilities.

    Industry compliance standards

    • ICH Q11 Development and Manufacture of Drug Substances
    • EU Guidelines for APIs from Chemical Synthesis
    • Japanese Pharmacopoeia General Notices on Drug Intermediates
    • ISO 9001:2015 Quality Management Systems—Pharma Synthesis

    Typical usage ratio

    • One equivalent as chiral precursor in route; batchwise addition with 1.15–1.3 stoichiometric equivalents based on downstream need for ring transformation

    Downstream process integration

    • Feeding into multi-step organic routes for substitution, amide bond formation, or azetidine expansion during early or mid-stage API production
    • Fmoc removal monitored via TLC or LC-MS; crude intermediates purified by crystallization or prep HPLC

    Final product types

    • CNS agent intermediates (e.g., for antipsychotic and anticonvulsant APIs)
    • Antiviral heterocyclic building blocks
    • Stereochemically defined azetidine platform intermediates
    • Drug substance R&D samples for regulatory submission

    3. Macrocyclic Compound Construction for Medicinal Chemistry

    Macrocycles incorporating azetidine rings display high target-binding selectivity in medicinal chemistry programs. Synthetic chemists use our material to introduce conformational locking into macrocyclic libraries intended for preclinical screening. The Fmoc group enables stepwise protection/deprotection so researchers can orthogonally assemble macrocyclic frameworks in both solution- and solid-phase routes. Stringent in-process checks ensure batch-to-batch reproducibility.

    Industry compliance standards

    • OECD Principles of Good Laboratory Practice (GLP)
    • USP <1225> Validation of Compendial Methods
    • Local site SOPs for preclinical compound management
    • REACH chemical registration for R&D use

    Typical usage ratio

    • 1–2 equivalents per macrocycle scaffold; modulated by ring size and peptide/aza-linkage proportion in designed libraries

    Downstream process integration

    • Added during early to middle ring-closure stages using standard peptide coupling reagents (e.g., HATU, PyBOP) followed by purification and mass confirmation
    • Deprotection and cyclization optimized to minimize byproduct formation; scale-up performed in jacketed reactors for temperature control

    Final product types

    • Macrocyclic inhibitor prototypes for pharmaceutical discovery
    • Preclinical pharmacology tool compounds
    • Small-molecule library members with azetidine constraints
    • Patent exploratory materials for target validation

    4. Chemical Biology Reagent Production

    Academic and industrial research centers deploy azetidine carboxylic acid derivatives to prepare labeling probes and peptidomimetic reagents for mode-of-action studies, protein mapping, and enzyme inhibition characterization. We supply the material for custom conjugation and tagging protocols where azetidine’s steric properties are critical for reagent stability and reactivity under physiological assay conditions.

    Industry compliance standards

    • ISO 13485:2016 for in vitro diagnostic reagent manufacture (where applicable)
    • Good Laboratory Practice (GLP) for reagent use
    • NIH Guidelines for Recombinant DNA and Chemicals
    • Material Transfer Agreements—Academic/Industry Collaboration

    Typical usage ratio

    • Variable: 0.5–5 mmol per synthetic batch, adjusted for reagent final concentration requirements in biochemical assays

    Downstream process integration

    • Coupled with biotin, fluorescent dyes, or clickable moieties in N-terminal modifications performed under anhydrous conditions
    • Incorporation into short peptide tags using automated SPPS, followed by quality control via LC-MS and HRMS

    Final product types

    • Peptide-based protein labeling kits
    • Bioactive probe molecules for cell imaging
    • Custom enzyme substrates containing azetidine residues
    • Molecular toolkits for chemical biology and screening

    5. Chiral Auxiliary Synthesis for Asymmetric Catalysis

    Catalyst designers and organometallic chemists use our protected azetidine derivative as a chiral auxiliary in developing new enantioselective ligands and transition-state stabilizers. Its solid-phase compatibility and clean removal allow the creation of modular screening arrays. Strict documentation and purity controls ensure processed auxiliaries meet international standards for trace metal and organics in catalytic studies.

    Industry compliance standards

    • ISO 17034 Reference Material Producer Accreditation (for catalyst screening libraries)
    • ACS Green Chemistry Institute: Best Practices
    • REACH Annex VII compliance for R&D-scale production
    • Internal QC standards: 99.5% enantiomeric excess for auxiliary inputs

    Typical usage ratio

    • 1 equivalent per ligand library member; scale: 100 mg to 200 g depending on experimental scope

    Downstream process integration

    • Ligand assembly in solution or on solid-phase resins
    • Integration completed after azetidine-Fmoc deprotection preceding catalytic application in asymmetric hydrogenation, cyclopropanation, or addition reactions

    Final product types

    • Screening libraries of chiral ligands
    • Single-use chiral auxiliaries for pharmaceutical process development
    • Reference samples for academic research and patent filings
    • Customized asymmetric catalysts for fine chemical synthesis
    Free Quote

    Competitive (S)-N-Fmoc-Azetidine-2-Carboxylic Acid prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    (S)-N-Fmoc-Azetidine-2-Carboxylic Acid: Hands-On Insights From the Manufacturer

    Direct Experience in Production

    Anyone who has worked at an actual chemical manufacturing site recognizes the value that (S)-N-Fmoc-Azetidine-2-Carboxylic Acid brings to peptide synthesis labs and research settings. For those of us producing this compound daily, it stands out as a key tool for chemists working at the frontiers of custom peptide design. While the world of synthetic amino acids is crowded, very few products match the flexibility and reliability our customers expect from this derivative.

    On our production floor, each batch of (S)-N-Fmoc-Azetidine-2-Carboxylic Acid demands strict attention, not only to chemical purity, but also to controlling the stereochemistry from the very first step. Rigor in process control ensures a consistent optical rotation and minimal racemization risk, which speaks directly to the concerns of synthetic chemists who use our material to build highly specific structures.

    Understanding The Model and Its Practical Role

    (S)-N-Fmoc-Azetidine-2-Carboxylic Acid is crafted for customers who need a reliable (S)-enantiomeric form, protected by the Fmoc group on the nitrogen. In this format, the compound integrates smoothly into established solid-phase peptide synthesis protocols. The azetidine ring, with its four-membered structure, produces a unique backbone constraint compared to standard alpha-amino acids. Researchers and developers often turn to this building block when exploring new sequences and scaffolds, seeking improved stability or bioactivity in peptide drug candidates.

    Our facility runs the solid-phase and stepwise synthesis of this product using standardized processes and automated purification techniques. This direct control over every step lets us supply batches that analysts verify for ≥98% purity by HPLC and essential chemical identity by NMR. These benchmarks matter because even the smallest impurity can interfere with downstream chemistry or analysis in customer labs.

    Technical Profile and Why Features Matter

    The Fmoc group brings advantages during peptide assembly by providing compatibility with conventional deprotection cycles; this means fewer surprises during chain elongation and reduces side-reactions that can spoil a time-consuming synthesis. In daily lab practice, it can take hours for a chemist to identify and troubleshoot sources of loss in yield or purity, so starting with precisely protected amino acids like this makes a direct difference in productivity.

    Azetidine-2-carboxylic acid itself, as a non-natural analog of proline, introduces a subtle but powerful change to peptide secondary structure. Its ring rigidity disrupts regular folding patterns, allowing researchers to control local backbone conformation and test the effects of this rigidity in everything from inhibitor design to material science. Our production experience shows strong demand from customers needing to synthesize macrocyclic peptides, conformationally restricted analogs, and bioactive peptide mimics for early-stage drug studies. Large molecule R&D groups value the difference in geometry that sets this material apart from open-chain or five-membered counterparts.

    Differences From Other Amino Acid Derivatives

    Having worked side-by-side with chemists who try to substitute other ring systems, we observe clear performance and reactivity distinctions in daily use. The azetidine ring resists oxidation and unwanted side-reactions better than more flexible beta- or gamma-amino acids. With our process refinement, crystalline Fmoc-azetidine-2-carboxylic acid exhibits excellent batch-to-batch quality, which reduces synthetic variability and procedural headaches when scaling up for longer peptides or library screens.

    In multi-step syntheses, switching from more common Fmoc-protected prolines or cyclic analogs fails to provide the same conformational bias. Peptide chemists using our azetidine derivative report improved control in helix formation and turn induction, helping predict folding outcomes that standard amino acids can’t deliver. This unique behavior traces back to the molecular constraint in the azetidine backbone—a difference observable in both NMR spectra and crystallographic data shared by industry collaborators.

    Manufacturing Mindset: Challenges, Solutions, and Experience

    Producing high-quality (S)-N-Fmoc-Azetidine-2-Carboxylic Acid takes more than simply scaling up a published procedure. Early attempts using imprecise conditions led to partial deprotection issues and incomplete Fmoc incorporation. Over time, careful adjustment of solvent ratios, reagent grades, and temperature controls has produced a robust and reproducible method now used to deliver commercial and custom grades.

    Our chemists keep a critical eye on the alpha-stereochemistry, performing chiral HPLC to confirm that no racemization creeps in during activation or protection steps. This attention is demanded by research clients working on applications where a single stereochemical change will undermine weeks of effort. Taken together, these measures help us maintain a low rejection rate—production floor data shows less than one batch per hundred requiring rework, driven mostly by raw material variation.

    Supporting Reliable Research for Peptide Innovation

    Across the pharmaceutical and biochemical research spectrum, solid building blocks shape the boundary between success and frustration. The Fmoc-azetidine-2-carboxylic acid we ship provides consistent chromatographic behavior, trouble-free Fmoc deprotection, and little tendency to create peptide truncations common when using lower-quality amino acid derivatives. Our process integration, from chemical synthesis through drying, packing, and shipment, prevents moisture uptake and microcontamination that can complicate reaction protocols. Analytical staff double-check each lot for water content and trace organics before release, recognizing how sensitive peptide chemistry can be to residual solvent and by-products.

    Clients reporting back from large-scale SPPS (solid-phase peptide synthesis) projects share that this material reduces resin fouling and minimizes background binding events. Such feedback has pushed us to optimize not only chemical purity, but also particle size and consistency for automated synthesizers.

    Meeting Industry Needs Through Chemical Expertise

    Our entire workflow—from sourcing starting azetidine ring precursors through to purification and analysis—runs in response to field demand, not generic expectations. High-throughput screening labs needing millimole quantities work with variations in batch size and delivery format, and our internal team stays flexible to meet those requests. Routine communication with end-users has taught us to avoid cross-contamination with similar ring systems or proline derivatives, managing separate packaging lines and validated cleaning protocols.

    Peptide manufacturers and biotech R&D groups also rely on rapid response to specification changes, especially as late-stage modification requests arise in drug candidate programs. With direct oversight of every production parameter, we deliver made-to-order lots that include certificate-supported proof of chemical identity, low endotoxin content, and tailored physical form when needed.

    Addressing Practical Concerns

    Some newcomers to azetidine chemistry worry about reduced solubility or altered reactivity compared to their usual suite of protected amino acids. Experience tells us that, using standard peptide solvents and protocols, the Fmoc-azetidine-2-carboxylic acid solution process is straightforward, with only minor adjustment required for swelling and coupling step times. This provides confidence for groups running manual or automated peptide machines. Despite the unique constraints of the molecule, ease-of-use stays high.

    Longevity matters when storing specialty amino acid derivatives. Over the years, we've improved batch stabilization using low-moisture lyophilization and inert-packaging systems. Clients working in variable climates report that our lots resist degradation and color change, a problem we've traced in the past to both residual acid content and atmospheric exposure at poorly controlled facilities.

    Scientific Relevance and Application Insights

    The value of (S)-N-Fmoc-Azetidine-2-Carboxylic Acid in research settings reflects new directions in molecular design. By incorporating subtle ring strain and increasing backbone rigidity, this building block lets biophysicists study peptide folding and binding events beyond the reach of proline analogs. Medicinal chemists leverage the distinctive structure to probe interactions at protein surfaces or receptor sites, confident that every batch mirrors the last. Industrial and academic groups frequently integrate the compound into exploratory libraries, using its unique features to challenge old ideas about structure-activity relationships.

    In our field, feedback runs both ways. Field scientists identify new bioactivity in modified peptides using this compound. We respond, where possible, by refining yield and improving throughput in the factory. Our team exchanges information regularly with customers on scale-up options or adjustment of protecting group strategies. This cycle of practical improvement and application-driven production builds a foundation for long-term reliability.

    Quality, Traceability, and Optimizing for Modern Chemistry

    Analytical method development plays a daily role in our operation. With each batch, staff use modern spectrometric and chromatographic techniques to verify not only chemical structure, but also residual solvent, water, and enantiomeric excess. Strong quality control ensures that harmful byproducts—especially those stemming from over-alkylation or incomplete deprotection—stay below detection limits. The traceability of each lot extends to supply chain documentation, giving researchers the confidence to publish and patent results grounded in reliable raw materials.

    Clients in regulated industries such as pharma or diagnostics don’t accept shortcuts on traceability. We invest in documentation and assign lots with unbroken chain-of-custody records, providing data that meets both internal and external audit standards. Over several years, we’ve built our systems not on theory, but in response to customer feedback from regulatory inspections and pre-clinical submission reviews.

    Ongoing Challenges and Looking Forward

    The global market for specialty amino acid derivatives continues to grow, with increasing complexity in the molecules chemists design. Reliable access to (S)-N-Fmoc-Azetidine-2-Carboxylic Acid relies on a secure supply of azetidine ring precursors and top-grade Fmoc-Cl, each subject to fluctuations in raw material markets. To manage interruptions, we maintain qualified secondary suppliers and stock levels that allow for rapid response. Involvement in supplier qualification gives us a real-world understanding of market volatility and its impact on customer projects.

    Customer expectations now include more than Chemistry 101 specifications. Sustainability and waste minimization factor into ongoing process improvements. Over the past three years, we have reduced solvent and energy consumption during the critical Fmoc-protection step, adopting more efficient washing plates and recovery of organics in our facility. Chemists in green chemistry roles give us feedback on routes that further cut waste, guiding our next rounds of production adjustment.

    Safety and Handling: A Ground-Level View

    Years of open dialogue with industrial safety experts and colleagues in QA/QC roles have improved our on-site practices. While (S)-N-Fmoc-Azetidine-2-Carboxylic Acid remains stable and manageable, safe storage and handling rely on moisture control and proper ventilation. Gloves and eye protection are common sense, based on direct experience in the facility. Our safety data and user guidance stem from hands-on monitoring, not copy-and-pasted generic advice.

    Spills, should they occur, are cleaned directly onto absorbent pads, avoiding dust dispersal. Disposal of even the smallest trimmings and waste from chromatography columns follows internal and local waste protocols, driven not only by regulation, but by real-world risk management practiced over thousands of manufacturing hours.

    Listening To Users and Improving The Product

    Technology evolves rapidly; so do user expectations. Synthetic chemists using automated synthesizers frequently report back on coupling kinetics, swelling behavior, or even odd color changes during runs. These reports receive direct attention from process engineers, who log and address trends in real-time. Maintenance of direct communication streams means user experiences shape product development, advancing both our chemistry and our relationships over time.

    On occasion, end-users try new coupling reagents or solvents, pressing for improvements in speed or scale. We learn together, providing technical back-and-forth and sharing what works well. By providing staff with hands-on experience and training, we close the loop between production and application, ensuring each new batch reflects the evolving needs of the research community.

    Summary of Hard-Earned Advantages

    From the perspective of a manufacturer—feet on the factory floor, years in the analytical lab—each lot of (S)-N-Fmoc-Azetidine-2-Carboxylic Acid leaves our site with more than just a box ticked on a checklist. It represents the culmination of technical troubleshooting, process adjustment, and real-world conversations with scientists at the cutting edge of peptide science. Whether the application is in macrocyclic inhibitor libraries, new biomaterials, or as a tool in structure-activity relationship studies, this azetidine derivative brings not only chemical uniqueness but the assurance of reliability and process transparency that end-users require.

    Trusted raw materials underpin the world’s most interesting chemical discoveries. In daily work, the attention paid to quality, documentation, and direct responsiveness sets the stage for our product to help researchers uncover new opportunities in molecular design, biology, and therapeutic development. From hands-on experience in production and ongoing engagement with the field, we continue shaping (S)-N-Fmoc-Azetidine-2-Carboxylic Acid into the product that today’s advanced chemistry demands.